Hans Gmuender

2.9k total citations · 1 hit paper
42 papers, 1.8k citations indexed

About

Hans Gmuender is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Hans Gmuender has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Genetics. Recurrent topics in Hans Gmuender's work include Carcinogens and Genotoxicity Assessment (9 papers), Cancer therapeutics and mechanisms (5 papers) and Gene expression and cancer classification (5 papers). Hans Gmuender is often cited by papers focused on Carcinogens and Genotoxicity Assessment (9 papers), Cancer therapeutics and mechanisms (5 papers) and Gene expression and cancer classification (5 papers). Hans Gmuender collaborates with scholars based in Switzerland, Netherlands and Germany. Hans Gmuender's co-authors include Heidrun Ellinger‐Ziegelbauer, Thomas Luebbers, Dirk Kostrewa, Jos Kleinjans, Holger Kuehne, Walter Huber, Daniel Bur, Francis Mueller, Markus Boehringer and Werner Klaus and has published in prestigious journals such as Nature Genetics, Scientific Reports and Environmental Pollution.

In The Last Decade

Hans Gmuender

42 papers receiving 1.8k citations

Hit Papers

DMSO induces drastic changes in human cellular processes ... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers

Hans Gmuender
Lu Zhou China
Yang Zhou China
William D. Pennie United States
Ghazi A. Damanhouri Saudi Arabia
William B. Mattes United States
Jeffrey W. Williams United States
Hans Gmuender
Citations per year, relative to Hans Gmuender Hans Gmuender (= 1×) peers Jeng‐Sen Tseng

Countries citing papers authored by Hans Gmuender

Since Specialization
Citations

This map shows the geographic impact of Hans Gmuender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Gmuender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Gmuender more than expected).

Fields of papers citing papers by Hans Gmuender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Gmuender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Gmuender. The network helps show where Hans Gmuender may publish in the future.

Co-authorship network of co-authors of Hans Gmuender

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Gmuender. A scholar is included among the top collaborators of Hans Gmuender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Gmuender. Hans Gmuender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verheijen, Marcha, Yannick Schrooders, Hans Gmuender, et al.. (2018). Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicology Letters. 294. 184–192. 29 indexed citations
2.
Choi, Hyunok, Pavel Rössner, Miroslav Dostál, et al.. (2017). Altered vulnerability to asthma at various levels of ambient Benzo[a]Pyrene by CTLA4, STAT4 and CYP2E1 polymorphisms. Environmental Pollution. 231(Pt 1). 1134–1144. 24 indexed citations
3.
Vineis, Paolo, Marc Chadeau‐Hyam, Hans Gmuender, et al.. (2016). The exposome in practice: Design of the EXPOsOMICS project. International Journal of Hygiene and Environmental Health. 220(2). 142–151. 189 indexed citations
4.
Rössner, Pavel, Elena Tulupová, Andrea Rössnerová, et al.. (2015). Reduced gene expression levels after chronic exposure to high concentrations of air pollutants. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 780. 60–70. 28 indexed citations
5.
Doktorova, Tatyana Y., Liesbeth Ceelen, Mireia Vilardell, et al.. (2014). Testing chemical carcinogenicity by using a transcriptomics HepaRG-based model?. PubMed. 13. 623–37. 19 indexed citations
6.
Rössnerová, Andrea, Elena Tulupová, Jana Schmuczerová, et al.. (2013). Factors affecting the 27K DNA methylation pattern in asthmatic and healthy children from locations with various environments. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 741-742. 18–26. 61 indexed citations
7.
Doktorova, Tatyana Y., Mathieu Vinken, Mireia Vilardell, et al.. (2013). Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models. Carcinogenesis. 34(6). 1393–1402. 42 indexed citations
8.
Leeuwen, Danitsja M. van, Hans Gmuender, Martinus Løvik, et al.. (2012). Global Gene Expression Analysis in Cord Blood Reveals Gender-Specific Differences in Response to Carcinogenic Exposure In Utero. Cancer Epidemiology Biomarkers & Prevention. 21(10). 1756–1767. 26 indexed citations
9.
Leeuwen, Danitsja M. van, Ralph W.H. Gottschalk, Hans Gmuender, et al.. (2012). Transcriptomic fingerprints in human peripheral blood mononuclear cells indicative of genotoxic and non-genotoxic carcinogenic exposure. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 746(2). 124–134. 12 indexed citations
10.
Boitier, Eric, Alexander Amberg, Valérie Barbié, et al.. (2011). A comparative integrated transcript analysis and functional characterization of differential mechanisms for induction of liver hypertrophy in the rat. Toxicology and Applied Pharmacology. 252(2). 85–96. 8 indexed citations
11.
Brolén, Gabriella, Mireia Vilardell, Jane Synnergren, et al.. (2011). Human Embryonic Stem Cell Derived Hepatocyte-Like Cells as a Tool for In Vitro Hazard Assessment of Chemical Carcinogenicity. Toxicological Sciences. 124(2). 278–290. 43 indexed citations
12.
Leeuwen, Danitsja M. van, Hans Gmuender, Solvor B. Stølevik, et al.. (2010). Transcriptomic Profile Indicative of Immunotoxic Exposure: In Vitro Studies in Peripheral Blood Mononuclear Cells. Toxicological Sciences. 118(1). 19–30. 26 indexed citations
13.
Matheis, Katja, Emmanuelle Com, Jean‐Charles Gautier, et al.. (2010). Cross-study and cross-omics comparisons of three nephrotoxic compounds reveal mechanistic insights and new candidate biomarkers. Toxicology and Applied Pharmacology. 252(2). 112–122. 26 indexed citations
14.
Stølevik, Solvor B., Unni C. Nygaard, Ellen Namork, et al.. (2010). In vitro cytokine release from human peripheral blood mononuclear cells in the assessment of the immunotoxic potential of chemicals. Toxicology in Vitro. 25(2). 555–562. 7 indexed citations
15.
Dip, Ramiro, et al.. (2009). Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food and Chemical Toxicology. 47(4). 787–795. 13 indexed citations
16.
Dip, Ramiro, Stephen D. Lenz, Jean‐Philippe Antignac, et al.. (2008). Global gene expression profiles induced by phytoestrogens in human breast cancer cells. Endocrine Related Cancer. 15(1). 161–173. 41 indexed citations
17.
Moretti, Stefano, Hans Gmuender, Stefano Bonassi, et al.. (2008). Combining Shapley value and statistics to the analysis of gene expression data in children exposed to air pollution. BMC Bioinformatics. 9(1). 361–361. 26 indexed citations
18.
Ellinger‐Ziegelbauer, Heidrun, et al.. (2007). Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 637(1-2). 23–39. 136 indexed citations
20.
Angehrn, Peter, Hans Gmuender, Paul Hebeisen, et al.. (1993). Cyclothialidine and its congeners: A new class of DNA gyrase inhibitors. Pharmacology & Therapeutics. 60(2). 367–380. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026